Swainsonine protects blood cell production from chemotherapy damage
Author Information
Author(s): Klein J-L D, Roberts J D, George M D, Kurtzberg J, Breton P, Chermann J-C, Olden K
Primary Institution: Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health
Hypothesis
Can swainsonine protect tumour-bearing mice without interfering with the anti-tumour effects of chemotherapy drugs?
Conclusion
Swainsonine protects both murine and human haematopoietic systems from the toxic effects of chemotherapy without hindering the drugs' ability to fight tumors.
Supporting Evidence
- Swainsonine reduced bone marrow toxicity from anticancer drugs in healthy mice.
- Swainsonine protected tumor-bearing mice from cyclophosphamide-induced toxicity.
- Swainsonine increased bone marrow cellularity and white blood cell counts in mice treated with AZT.
- Swainsonine restored progenitor cell levels in the presence of AZT doses that typically reduce them.
Takeaway
Swainsonine helps protect the body from the bad effects of cancer treatments, making it easier for people to stay healthy while fighting cancer.
Methodology
The study involved testing swainsonine's effects on mice with tumors and human myeloid progenitor cells in vitro.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website